Shamim Ruff - Mar 10, 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC (RETA)

Role
Director
Signature
/s/ Tracy Herson, attorney-in-fact
Stock symbol
RETA
Transactions as of
Mar 10, 2023
Transactions value $
-$282,568
Form type
4
Date filed
3/13/2023, 05:23 PM
Previous filing
Jun 9, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RETA Class A common stock Options Exercise $5.44K +199 +3.81% $27.32 5.42K Mar 10, 2023 Direct
transaction RETA Class A common stock Options Exercise $46.1K +1.33K +24.46% $34.76 6.75K Mar 10, 2023 Direct
transaction RETA Class A common stock Options Exercise $147K +4.22K +62.46% $34.76 11K Mar 10, 2023 Direct
transaction RETA Class A common stock Sale -$481K -5.74K -52.36% $83.73 5.22K Mar 10, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RETA Stock Option (right to buy) Options Exercise $0 -199 -100% $0.00* 0 Mar 10, 2023 Class A common stock 199 $27.32 Direct F2
transaction RETA Stock Option (right-to-buy) Options Exercise $0 -1.33K -74.96% $0.00 443 Mar 10, 2023 Class A common stock 1.33K $34.76 Direct F3
transaction RETA Stock Option (right-to-buy) Options Exercise $0 -4.22K -75% $0.00 1.41K Mar 10, 2023 Class A common stock 4.22K $34.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $83.67 to $83.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The options vested in two equal installments on March 10, 2022 and June 10, 2022.
F3 The options vest in four equal installments on September 14, 2022, December 8, 2022, March 1, 2023, and June 7, 2023, subject to continued service through each vesting date.